<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04968457</url>
  </required_header>
  <id_info>
    <org_study_id>PEC 15-10-001</org_study_id>
    <nct_id>NCT04968457</nct_id>
  </id_info>
  <brief_title>Multicenter Post-marketing Survey of SEBBIN Group Silicone Gel-filled Breast Implants</brief_title>
  <acronym>IM02</acronym>
  <official_title>Multicenter Post-marketing Survey of SEBBIN Group Silicone Gel-filled Breast Implants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Groupe SEBBIN</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Groupe SEBBIN</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to allow Groupe SEBBIN to communicate to competent authorities and to&#xD;
      the scientific community data relative to the safety and effectiveness of SEBBIN silicone&#xD;
      gel-filled breast implants.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 2014</start_date>
  <completion_date type="Anticipated">January 2027</completion_date>
  <primary_completion_date type="Anticipated">January 2027</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Complication</measure>
    <time_frame>At 10 years of follow-up</time_frame>
    <description>complication rate</description>
  </primary_outcome>
  <enrollment type="Actual">908</enrollment>
  <condition>Breast Implant; Complications</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Enrollment in the study was proposed to women over 18-year who were scheduled for a breast&#xD;
        augmentation or breast reconstruction with SEBBIN silicone gel-filled breast implants.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The patient is at least 18-year-old.&#xD;
&#xD;
          -  The patient is genetically a woman.&#xD;
&#xD;
          -  The patient is candidate to a breast augmentation or breast reconstruction with&#xD;
             silicone gel-filled breast implants.&#xD;
&#xD;
          -  The patient gets all information regarding the study and signs the informed consent&#xD;
             relative to the use of her personal data.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  The patient is pregnant or breastfeeding.&#xD;
&#xD;
          -  The patient has silicone implants somewhere else than in the breast.&#xD;
&#xD;
          -  The patient was diagnosed with one of the following pathologies:&#xD;
&#xD;
               -  Systemic lupus erythematous, Sjogren syndrome, scleroderma, polymyositis, or any&#xD;
                  other connective tissue disease.&#xD;
&#xD;
               -  Rheumatoid arthritis, crystalline arthritis, infectious arthritis,&#xD;
                  spondyloarthropathies, or any other inflammatory arthritic disease.&#xD;
&#xD;
               -  Arthritis, fibromyalgia, chronic fatigue syndrome, or any other mechanic or&#xD;
                  degenerative non-inflammatory rheumatic disease.&#xD;
&#xD;
          -  The patient has a pathology that could delay healing (does not apply to the&#xD;
             reconstruction group).&#xD;
&#xD;
          -  The patient has cancer (does not apply to the reconstruction group).&#xD;
&#xD;
          -  The patient has anatomical or physiological conditions that could lead to&#xD;
             postoperative complications.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 6, 2021</study_first_submitted>
  <study_first_submitted_qc>July 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 20, 2021</study_first_posted>
  <last_update_submitted>July 19, 2021</last_update_submitted>
  <last_update_submitted_qc>July 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

